| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CBIN.10139 |
| P698 | PubMed publication ID | 23716467 |
| P2093 | author name string | Wei Meng | |
| Lin Lu | |||
| Bei Zhang | |||
| Yuan Liu | |||
| Jianping Xu | |||
| Haiyan Hu | |||
| Yanwei Qing | |||
| Yuan Shen | |||
| P2860 | cites work | Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis | Q24609213 |
| Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas | Q24652219 | ||
| Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers | Q28251838 | ||
| let-7 and miR-17-92: small-sized major players in lung cancer development | Q28291431 | ||
| The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors | Q28295428 | ||
| miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma | Q34123719 | ||
| MiR-200c regulates Noxa expression and sensitivity to proteasomal inhibitors | Q34277271 | ||
| Myc overexpression brings out unexpected antiapoptotic effects of miR-34a | Q35084362 | ||
| Oestrogen causes degradation of KLF5 by inducing the E3 ubiquitin ligase EFP in ER-positive breast cancer cells | Q37070467 | ||
| Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. | Q37680260 | ||
| Enhancing activity and overcoming chemoresistance in hematologic malignancies with bortezomib: preclinical mechanistic studies | Q37687673 | ||
| MicroRNA-mediated gene silencing | Q37726449 | ||
| Triptolide inhibits the proliferation of cells from lymphocytic leukemic cell lines in association with downregulation of NF-κB activity and miR-16-1*. | Q37727428 | ||
| Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers | Q37812094 | ||
| The ubiquitin+proteasome protein degradation pathway as a therapeutic strategy in the treatment of solid tumor malignancies | Q37847605 | ||
| The ubiquitin-proteasome system (UPS) and the mechanism of action of bortezomib. | Q37866823 | ||
| Targeting the ubiquitin-proteasome pathway: an emerging concept in cancer therapy | Q37913447 | ||
| P21 (waf1/cip1) is required for non-small cell lung cancer sensitive to Gefitinib treatment | Q39535731 | ||
| The miR-17-92 microRNA cluster regulates multiple components of the TGF-β pathway in neuroblastoma | Q39621978 | ||
| EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer | Q40361923 | ||
| Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells | Q44323774 | ||
| P433 | issue | 10 | |
| P921 | main subject | microRNA | Q310899 |
| endometrial cancer | Q944777 | ||
| P304 | page(s) | 1114-1121 | |
| P577 | publication date | 2013-06-24 | |
| P1433 | published in | Cell Biology International | Q1254690 |
| P1476 | title | Bortezomib induces apoptosis of endometrial cancer cells through microRNA-17-5p by targeting p21. | |
| P478 | volume | 37 |
| Q92368951 | Bortezomib attenuates renal interstitial fibrosis in kidney transplantation via regulating the EMT induced by TNF-α-Smurf1-Akt-mTOR-P70S6K pathway |
| Q90451191 | Dexrazoxane Protects Cardiomyocyte from Doxorubicin-Induced Apoptosis by Modulating miR-17-5p |
| Q52655134 | Downregulation of microRNA-17-5p inhibits drug resistance of gastric cancer cells partially through targeting p21. |
| Q39317584 | Epigenetics in endometrial carcinogenesis - part 2: histone modifications, chromatin remodeling and noncoding RNAs. |
| Q51503055 | MicroRNA-17 promotes normal ovarian cancer cells to cancer stem cells development via suppression of the LKB1-p53-p21/WAF1 pathway. |
| Q26780358 | MicroRNAS in endometrial cancer: recent advances and potential clinical applications |
| Q38258014 | Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies |
| Q36540685 | Signaling mechanisms of bortezomib in TRAF3-deficient mouse B lymphoma and human multiple myeloma cells. |
| Q38820391 | The future therapy of endometrial cancer: microRNA's functionality, capability, and putative clinical application. |
| Q38362213 | The role of microRNAs in the pathogenesis of endometrial cancer: a systematic review. |
| Q36719087 | miR-31 and miR-17-5p levels change during transformation of follicular lymphoma |
Search more.